*Elan Pharmaceuticals, Inc, South San Francisco
‡Department of Medicine, University of California, San Francisco, CA
†Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Boston, MA
Reprints: Henry Michael Arrighi, PhD, MSPH, Epidemiology, Elan Pharmaceuticals, Inc, 800 Gateway Boulevard, South San Francisco, CA 94080 (e-mail: [email protected]).
Received for publication September 3, 2008; accepted January 17, 2009
Supported by funding from Elan Pharmaceuticals, Inc.
Disclosures: Henry Michael Arrighi and Raymond J. Townsend are employees of Elan Pharmaceuticals, Inc. Ivan M. Lieberburg was an employee of Elan Pharmaceuticals, Inc, during the course of this work Elan Pharmaceuticals, Inc, provided funding to Peter J. Neuman.